½Å¾à°³¹ß ½ÃÀåÁ¶»çº¸°í¼­

Global Information¿¡¼­´Â ÇöÀç 25°³ ÀÌ»óÀÇ ÃâÆÇ»ç¿Í ¾Ö³Î¸®½ºÆ®°¡ ¹ß°£ÇÑ 1,000°³ ÀÌ»óÀÇ ½Å¾à°³¹ß(Drug Discovery)°ü·Ã º¸°í¼­¸¦ º¸À¯Çϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ºÐ¾ß¿Í Ç׸ñÀÇ º¸°í¼­¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀ» ºñ·ÔÇØ ½Å¾à°³¹ß ±â¼ú °ü·Ã ¾Æ¿ô¼Ò½Ì¿¡ À̸£±â±îÁö ½Å¾à°³¹ß ½ÃÀåÀÇ ¸ðµç ±¹¸é¿¡ ´ëÇØ ´Ù¾çÇÑ °üÁ¡¿¡¼­ ºÐ¼®Çß½À´Ï´Ù. °í°´ÀÇ ´ÏÁî¿¡ ¸Â´Â ÃÖÀûÀÇ º¸°í¼­¸¦ ÃßÃµÇØ µå¸®°í ÀÖÀ¸´Ï ¹®ÀÇ Áֽñ⠹ٶø´Ï´Ù.

1 - 25 (Àüü: 764°Ç)
¼¼°èÀÇ ÀǾàǰ ¹«±Õ ÀÌ¼Û ½ÃÀå
Pharmaceutical Aseptic Transfer
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹Ì»ý¹° °Ë»ç ¼öŹ ±â°ü(CRO) ¼­ºñ½º ½ÃÀå
Microbiology Contract Research Organization (CRO) Services
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¶¸°°Å-¿¤¸®½¼ ÁõÈıº Ä¡·á ½ÃÀå
Zollinger-Ellison Syndrome Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹× Á¦Á¦ ¾Æ¿ô¼Ò½Ì ½ÃÀå
Outsourced Clinical Trials and Formulation
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñÀÓ»ó½ÃÇè ½ÃÀå
Non-Clinical Trials
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇѼ¾º´ Ä¡·á ½ÃÀå
Leprosy Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ã¼¿Ü µ¶¼º ½ÃÇè¹ý ½ÃÀå
In-Vitro Toxicology Assays
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÇÐ ÀÓ»ó½ÃÇè¼öʱâ°ü ½ÃÀå
Neurology Contract Research Organization
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¦¾à CRO ½ÃÀå
Pharmaceutical CRO
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿À¹Í½º ±â¹Ý ÀÓ»ó½ÃÇè ½ÃÀå
Omics-based Clinical Trials
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓ»ó½ÃÇè¿ë ÀǾàǰ CDMO ½ÃÀå
Investigational New Drug CDMO
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ »ýŵ¶¼º ¿¬±¸ ½ÃÀå
Ecotoxicological Studies
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¿¹Ãø ¾à¹° ¹ÝÀÀ ¸ðµ¨¸µ¿ë AI ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2034³â) : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ÄÄÆ÷³ÍÆ®, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ±â´É, Àü°³, ¼Ö·ç¼Ç
AI for Predictive Drug Response Modeling Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, End User, Functionality, Deployment, Solutions
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,750 £Ü 6,692,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇコÄÉ¾î °è¾à ÆÇ¸Å Á¶Á÷ ½ÃÀå
Healthcare Contract Sales Organizations
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °æÇǵ¶¼º ½ÃÇè ½ÃÀå
Dermal Toxicity Testing
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿¹Ãø µ¶¼ºÇÐ AI ½ÃÀå(2025-2029³â)
Global AI in Predictive Toxicology Market 2025-2029
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 2,500 £Ü 3,522,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¸ÅĪ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
Clinical Trials Matching Software
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÓ»ó½ÃÇè Àåºñ ¹× º¸Á¶ ¼Ö·ç¼Ç ½ÃÀå
Clinical Trial Equipment and Ancillary Solutions
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È­ÇÐÁ¤º¸ÇÐ ½ÃÀå
Chemoinformatics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½ÉÀå ÀΰøÁö´É ¸ð´ÏÅ͸µ ¹× Áø´Ü ½ÃÀå
Cardiac Artificial Intelligence Monitoring and Diagnostics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ö»ý »ýÅ µ¶¼º ¿¬±¸ ½ÃÀå
Aquatic Ecotoxicological Studies
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×ü ¼öŹ °³¹ß ¹× Á¦Á¶ ±â°ü(CDMO) ½ÃÀå
Antibody Contract Development and Manufacturing Organization
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå : ¼­ºñ½ºº°, À¯Çüº°, »ç¾÷ ±Ô¸ðº°, ¿ø·áº°, ºÐÀÚ À¯Çüº°, Ä¡·á ¿µ¿ªº°, Áö¿ªº° ¿¹Ãø(-2030³â)
Biopharmaceutical Contract Manufacturing Market by Service, Type, Scale, Source, Therapy Area, Molecule Type - Global Forecast to 2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,950 £Ü 6,974,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ã¼¿Ü µ¶¼º ½ÃÇè ½ÃÀå - »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ±â¼úº°, ¿ëµµº°, ¹æ¹ýº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, By Method, By End-User, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,500 £Ü 6,340,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀúºÐÀÚ À̳뺣ÀÌÅÍ CDMO ½ÃÀå
Small Molecule Innovator CDMO
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,242,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.